Laetitia Prival

The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia.

A. Eschalier, Jérôme Ruel, J. Busserolles, 2015, Cell reports.

Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin

D. A. Barrière, A. Eschalier, M. Lazdunski, 2018, Neuropharmacology.

The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice

D. A. Barrière, A. Eschalier, J. Busserolles, 2021, International journal of molecular sciences.

The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats

P. Marin, Y. Aissouni, F. Lamaty, 2023, Biomolecules.

Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity

A. Eschalier, J. Busserolles, D. Balayssac, 2021, Molecular Neurobiology.

The TREK-1 potassium channel is involved in both the analgesic and anti-proliferative effects of riluzole in bone cancer pain.

M. Meleine, J. Busserolles, Y. Aissouni, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Testosterone‐androgen receptor: The steroid link inhibiting TRPM8‐mediated cold sensitivity

M. Etienne, A. Eschalier, M. Meleine, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.